CD44 and prostate carcinoma: Accumulating evidence has demonstrated the existence of prostate cancer stem cells, which can be been enriched by sorting for CD44+/CD133+ expression [4,5] or by selecting cells that have the capacity to exclude Hoechst dye [6] or form spheres in serum-free suspension culture [7,8].